section name header

Evidence summaries

Facilitated Percutaneous Coronary Intervention (Pci) Vs Pci Alone

Facilitated percutaneous coronary intervention, particularly by thrombolytic therapy, increases mortality, reinfarction, urgent revascularisation and bleeding. Level of evidence: "A"

A systematic review 1 including 17 studies with a total of 4504 subjects was abstracted in DARE. The drugs of interest were high-dose heparin, platelet glycoprotein IIb/IIIa inhibitors, full-dose thrombolytic therapy, reduced-dose thrombolytic therapy, or a combination of both platelet glycoprotein IIb/IIIa inhibitors and reduced-dose thrombolytic therapy. The results are mostly influenced by thrombolytic therapy. The following outcomes were significantly increased as a result of the facilitated intervention compared with the primary PCI: mortality (5% versus 3%) as a (OR 1.38, 95% CI: 1.01 to 1.87, P=0.04); nonfatal reinfarction (3% versus 2%) (OR 1.71, 95% CI: 1.16 to 2.51, P=0.006); urgent target vessel revascularisation (4% versus 1%) (OR 2.39, 95% CI: 1.23 to 4.66, P=0.010); major bleeding (7% versus 5%) (OR 1.51, 95% CI: 1.10 to 2.08, P=0.010). Rates of haemorrhage (0.7% versus 0.1%, P=0.0014) and total stroke (1.1% versus 0.3%, P=0.0008) were higher in those receiving thrombolytic therapy as part of the intervention.

References

Primary/Secondary Keywords